Q2 Results Confirm Recovery Trajectory but AI Upside Still in Early Innings

What happened

Cognex reported Q2 2026 revenue of $292 million, up 21% year-over-year and ahead of the $280–300 million guidance range, with adjusted EBITDA margin of 30.5% driven by logistics, semiconductor, and packaging strength, while automotive stayed soft. Gross margin held at 71.2% on favorable mix and cost actions, and management highlighted that OneVision and new In-Sight AI systems are moving from pilot to multi-site deployments, though material revenue contribution remains a second-half 2026 story. The company raised full-year revenue growth guidance to low-teens from mid-single digits, citing broad-based demand and accelerating AI vision adoption. Despite the beat, the stock reacted modestly as the premium valuation—over 70x trailing earnings—already discounts multi-year AI-driven growth. The results de-risk the near term but do not change the balanced risk/reward until AI revenue proves recurring and scalable.

Implication

The Q2 beat and raised guidance confirm that Cognex’s core machine vision business is on a solid recovery path, with AI platforms starting to contribute. However, with the stock trading at ~64x forward earnings, the risk/reward remains balanced. Near-term de-risking is positive, but until AI revenue becomes a material and recurring driver, the stock is likely range-bound. We maintain a WAIT rating and would view a pullback toward the $52–$55 range as an opportunity to build a position to capture the long-term AI-led automation trend.

Thesis delta

The Q2 results met our near-term checkpoints, reducing the risk of a demand or margin miss. However, AI platform contribution remains more promise than proof, and the current valuation already discounts significant success. Our base-case probability edges up slightly, but the investment case still requires patience for a better entry point.